An observational study in Midface Volume Deficit and Midface Contour Deficiency, sponsored by Galderma R&D. Recruiting at 1 site in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-23.
Sponsored by Galderma R&D (part of Galderma Group AG) · Observational
This is a non-interventional, multi-center, study designed to evaluate the long-term safety and effectiveness of Sculptra™ for the correction of midface volume deficit and/or midface contour deficiency in subjects of Chinese origin in standard clinical practice.
The total duration of the study is estimated to be approximately 19 months (not including 12 months of retrospective period).
Effectiveness and safety data will be collected for up to 24 months after the initial treatment, including 12 months of retrospective period and another 12 months of prospective period.
Galderma R&D is the lead sponsor of 283 studies on the registry; 10 are open to participants now.
Of its 60 completed or terminated interventional studies of FDA-regulated products, 55 (92%) have results posted.
Counted across the registry records on this site, refreshed daily.
Subjects aged 18 years or older, and who received Sculptra treatment in the midface, within the last 11-12 months, prior to screening.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Incidence, intensity, duration, and onset of related adverse events (AEs) collected from medical records since first treatment
Time frame: From the subject's first midface Sculptra treatment to the end of the study, 24 months after the first treatment.
Incidence, intensity, duration, and onset of related AEs detected during focused physical examinations.
Time frame: At Day 1 and Month 12
Incidence, intensity and duration of pre-defined symptoms collected using a Subject Complaint Questionnaire
Time frame: At Day 1, Month 6 and Month 12
Percentage of subjects in each response category for the Subjects Safety Satisfaction Questionnaire
Time frame: At Day 1, Month 6 and Month 12
Percentage of responders, defined by having "Improved", "Much improved" or "Very much improved" according to the Global Aesthetic Improvement Scale (GAIS) on both sides of the face combined, as assessed by the subject and the investigator
Time frame: At Day 1 and Month 12
Percentage of subjects in each response category for each question in the Subject Effectiveness Satisfaction Questionnaire
Time frame: At Day 1, Month 6 and Month 12
Percentage of subjects in each response category for each question in the Skin Quality Improvement Questionnaire
Time frame: At Day 1, Month 6 and Month 12
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.